February 2026 | Adherium Investor Update

Adherium CEO Dawn Bitz shares an update on the Company's respiratory digital health platform, highlighting strong real-world data showing significant improvements in medication adherence for asthma and COPD patients. The Company is scaling recurring revenue through remote patient monitoring while positioning for larger value-based care contracts with US insurers.